Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
i
Other names:
MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog, BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2, BCL6, BCL5, BCL6A, LAZ3, ZBTB27, ZNF51, B-cell CLL/lymphoma 6
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4609
;
596
;
604
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
MYC rearrangement + BCL2 rearrangement (22)
MYC rearrangement + BCL6 rearrangement (9)
MYC rearrangement (7)
BCL2 mutation (6)
MYC mutation (5)
BCL6 rearrangement (5)
MYC translocation (4)
BCL2 G101V (4)
MYC translocation + BCL2 translocation (3)
BCL2 rearrangement (3)
BCL2 D103Y (2)
BCL6 translocation (2)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
MYC translocation + BCL6 translocation (1)
MYC translocation + BCL6 translocation + BCL2 translocation (1)
BCL2 F104I (1)
BCL2 G101V + SF3B1 mutation (1)
BCL2 N103E (1)
BCL2 N103Y (1)
BCL2 N107_N110dup (1)
BCL2 V156N (1)
EZH2 mutation + BCL2 translocation (1)
TP53 mutation + BCL2 rearrangement (1)
MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)
BCL2 translocation (0)
MYC rearrangement + BCL2 rearrangement (22)
MYC rearrangement + BCL6 rearrangement (9)
MYC rearrangement (7)
BCL2 mutation (6)
MYC mutation (5)
BCL6 rearrangement (5)
MYC translocation (4)
BCL2 G101V (4)
MYC translocation + BCL2 translocation (3)
BCL2 rearrangement (3)
BCL2 D103Y (2)
BCL6 translocation (2)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
MYC translocation + BCL6 translocation (1)
MYC translocation + BCL6 translocation + BCL2 translocation (1)
BCL2 F104I (1)
BCL2 G101V + SF3B1 mutation (1)
BCL2 N103E (1)
BCL2 N103Y (1)
BCL2 N107_N110dup (1)
BCL2 V156N (1)
EZH2 mutation + BCL2 translocation (1)
TP53 mutation + BCL2 rearrangement (1)
MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)
BCL2 translocation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
lisocabtagene maraleucel
Sensitive: A2 - Guideline
lisocabtagene maraleucel
Sensitive
:
A2
lisocabtagene maraleucel
Sensitive: A2 - Guideline
lisocabtagene maraleucel
Sensitive
:
A2
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Lymphoma
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Lymphoma
lisocabtagene maraleucel
Sensitive: C2 – Inclusion Criteria
lisocabtagene maraleucel
Sensitive
:
C2
lisocabtagene maraleucel
Sensitive: C2 – Inclusion Criteria
lisocabtagene maraleucel
Sensitive
:
C2
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
loncastuximab tesirine-lpyl
Sensitive: C3 – Early Trials
loncastuximab tesirine-lpyl
Sensitive
:
C3
loncastuximab tesirine-lpyl
Sensitive: C3 – Early Trials
loncastuximab tesirine-lpyl
Sensitive
:
C3
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
axicabtagene ciloleucel
Sensitive: C3 – Early Trials
axicabtagene ciloleucel
Sensitive
:
C3
axicabtagene ciloleucel
Sensitive: C3 – Early Trials
axicabtagene ciloleucel
Sensitive
:
C3
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Diffuse Large B Cell Lymphoma
acalabrutinib
Sensitive: C4 – Case Studies
acalabrutinib
Sensitive
:
C4
acalabrutinib
Sensitive: C4 – Case Studies
acalabrutinib
Sensitive
:
C4
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Lymphoma
MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement
Lymphoma
SGN-CD19B
Sensitive: D – Preclinical
SGN-CD19B
Sensitive
:
D
SGN-CD19B
Sensitive: D – Preclinical
SGN-CD19B
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login